May 13, 2026 05:10PM
May 13, 2026 04:01PM
Mar 23, 2026 06:47AM
Mar 12, 2026 04:00PM
Jan 7, 2026 07:00AM
Dec 26, 2025 08:30AM
Dec 26, 2025 08:30AM Adicet Bio Announces Reverse Stock Split
Nov 19, 2025 04:15AM
Nov 5, 2025 04:02PM
Nov 5, 2025 04:01PM
Oct 16, 2025 07:00AM
Oct 16, 2025 07:00AM
Oct 7, 2025 06:45AM
Oct 7, 2025 06:45AM Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
Aug 13, 2025 04:11AM
Aug 7, 2025 04:01PM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM
May 6, 2025 05:43PM
May 6, 2025 04:01PM
Apr 17, 2025 07:01AM Adicet Bio (ACET) Appoints Michael Grissinger to the Board of Directors
Apr 17, 2025 07:00AM
Mar 6, 2025 05:20PM
Mar 6, 2025 04:01PM
Feb 27, 2025 07:02AM
Feb 27, 2025 07:00AM
Feb 5, 2025 07:10AM
Feb 5, 2025 07:10AM Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement
Jan 8, 2025 04:10PM
Jan 8, 2025 04:10PM
Dec 19, 2024 07:03AM
Dec 19, 2024 07:00AM
Dec 18, 2024 07:00AM
Dec 18, 2024 07:00AM
Nov 18, 2024 04:00PM Adicet Bio (ACET) Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Nov 18, 2024 04:00PM
Nov 18, 2024 07:09AM
Nov 18, 2024 07:00AM
Nov 16, 2024 09:00AM
Nov 7, 2024 06:14AM
Nov 6, 2024 04:00PM
Nov 6, 2024 04:00PM Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates
Oct 16, 2024 07:01AM
Oct 16, 2024 07:00AM
Sep 30, 2024 07:00AM
Sep 19, 2024 07:02AM
Sep 19, 2024 07:00AM
Aug 19, 2024 07:01AM
Aug 19, 2024 07:00AM Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
Aug 14, 2024 06:11AM

1,197,253 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All